New imaging study aims to sharpen stroke risk detection

NCT ID NCT07079345

First seen Nov 20, 2025

Summary

This observational study will use combined PET/MR scans to measure blood flow and glucose metabolism in the brains of 200 people with severe carotid artery narrowing. Participants have already had a mini-stroke or stroke in the past year. The goal is to develop better imaging markers to evaluate disease and guide treatment, not to test a new drug or procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE, ISCHEMIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Xuanwu Hospitail, Capital Medical University

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better imaging tools to assess stroke risk and guide treatment decisions for patients with narrowed carotid arteries.

What could go wrong

This is an observational study, not a treatment trial. It will not directly test a new therapy, and the findings may not change current clinical practice.

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.